WAMIDH TELLOW: Open Payments
NPI 1235717042 · LINDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$529 in 18 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $49 · 2025 $529
Food & beverage: $513Education: $16
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $137 |
| Lilly USA, LLC | 1 | $118 |
| Amgen Inc. | 5 | $76 |
| Novo Nordisk Inc | 3 | $62 |
| Corcept Therapeutics | 2 | $53 |
| ABBVIE INC. | 3 | $49 |
| GlaxoSmithKline, LLC. | 2 | $33 |
Products named: Kerendia, ZEPBOUND, Korlym, VRAYLAR, OTEZLA, REPATHA, SHINGRIX, Wegovy.
Industry payments across NJ — which companies pay providers there.
